Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ditto...Thanks Techxen.....keep up the great PR and Ad work for CTSO!
FYI...... The Trump Administration has created a $2.5 billion emergency coronavirus plan, which will include funds for vaccines and treatment. The proposed budget comes after stocks took a hit across the globe on Monday, amid growing concerns the coronavirus could hit the global economy. The $2.5 billion response plan includes $1.25 billion in new funding, as well as $535 million that had been earmarked to fight Ebola. Although close to 80,000 people have been infected by the disease, which has claimed over 2,500 lives, the U.S. has only seen 14 cases over seven states, according to The Associated Press.
Of course they did.....and that is a lot cheaper and quicker than having to arrange and pay for “real-time trials” with the specific “high cytokines” target population already under attack! Just hoping for some successes before spring/summer!
That and they will release news to create a run-up and then sell into that run-up thereby slowing or stopping the run-up as they collect their cash.
Rinse and repeat-------I apologize in advance for feeling a little or a lot pessimistic today! Ive been here over 9 years back to MetaSorb days.....
still believe but no longer as sure why!
correct me if I'm mistaken......but aren't both of the European conferences NEXT WEEK!!!!!!
GLTA
Eskay---I am in agreement with you and I for one will take base-building in the 11.75 - 12.35 range quite happily...…..More to come when the time is right for it!
GLTA
Kid-A, I sold 5k shares in past 6 months but still holding 25k.....so, I understand "nervous" --- Canes sounded more disengenous than nervous....but that may just be how I took it, but it seemed like several others on here felt like I did! Good luck to all of us at any rate!
Onward and upward and hopefully at a nice sustainable pace!
GLTA
Exactly right Orangecat and Canes16 is just fanning the flames trying desparately to TALK it down......it is time to put up and pay up and don't look back. Accumulate wherever and whenever you can folks! JMHO.
GLTA
link please....
Bold analyst at Cowan I see!!!!!
GLTA
True, but the cartridge requires the machine to pump the blood through it......the razor blade is useless without the razor as Chan often refers to CTSO business model as the blade in someone else’s razor! Too bad it takes loss of life to bring attention to the news! SOC can’t come soon enough!
suspect he is fully aware......but he isn't being endorsed.....ie-getting paid by Cytosorbents!
GLTA
CRC
Raptor.....I agree with your analysis and I have been in MSBT/CTSO since 2008/2009---I'll have to check. Your scenario suggesting 70-80 in a couple years is alright with me as well, I just hope it continues slowly climbing from now to then and maybe 30-40 in a year or so.....many, many positives but we all know the Holy Grail is FDA approval and that is most likely 2020 at the earliest!
GLTA
CRC
Thanks for clarifying.....and upon this we agree: a forward split will not be in the cards----a buy-out or a strategic alliance/partnership is far more likely and would occur well before a forward split, IMHO
GLTA
eskay….while it is likely at least 1-1.5 years out and possibly up to 3 years out, are you suggesting sales and stock price will stay flat until then or is it more likely to continue climbing in both providing for an even better springboard for when the Big Event does occur, which is increasingly more and more probable as each day, week and month go by!
GLTA,
CRC
Thanks JCKRDU.......
Does anyone know if this submission of findings on Keytruda/ADXS Phase 1/2 Trial has been accepted/announced??
"These findings and additional correlative immunologic data from this ongoing trial have been submitted for presentation at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in Frankfurt, Germany, in September."
GLTAL's
I seem to recall expecting the Merck/ADXS PSA/Keytruda trial report out sometime in September timeframe---anybody else verify this?
GLTAL's
must be out of breath......it ain't inflating any!!!!!
GLTAL's
Well, if this is anywhere near his intentions and attitude, and not just "sour grapes" projecting it upon him.....then his balls should be smashed with a "ball-peen" hammer!!!
GLTAL's
Thanks Bourbon and Iggy, that sounds good! Sure don't want to have to put up more capital to convert the warrants to shares first!
GLTAL's
Bourbon--do you know exactly how a BO would effect our warrants?
CRCook
Excel, from your lips to Gods ears!!!!!!
GLTAL's
Equal.....understand, but what is the possible end-game---why would "they" do this for over 2 years? How does it end---what do they ever get out of it---they cant increase their shares w/o disclosing after 4 days as I understand it? I Just dont get it......
Lifter, I think he real reason has to do with obtaining participants for these early Phase 1 and 2 trials---who wants to sign up to do trials with an unknown, upstart baby-bio (that's constantly being bashed on its own message boards)that has a 33-50% chance of only getting a placebo in the first place????
GLTAL's
OK Barrell.....while true there have been NO trials with control arms, double blinded, etc.----study carefully the RTOG and GOG trials and results. In GOG 265 Phase 2 using exactly same design and criteria as many others over many years the GOG trial revealed AXAL to compare favorably (38% to 56% OR) to all including the blockbuster drug AVASTIN (30% OR)...and as I recall, this was with much worse off patients some or most of whom had already failed with AVASTIN. Then there is the 10/10 CR in Anal trial now approaching 36 months with ~89% CR/OR vs 45% 3Yr CR/OR for SOC. And the 8/8 CR in H&N trials............all without control arms, but not anything to sneeze at or just ignore as in right off to chance!
The Aim2cerve Phase 3 is the first axal trial with blind controls, and I'm sure you are well aware of that.
GLTAL's
I understand and agree....however, in his position and connections, I would think/hope he may could persuade for "compassionate use" authorization.....
What path does that take....is it conceivable?
Dr. Michael D Becker is a Biotech entrepreneur who was once Chair of BioNJ as I believe DOC is/was. Well Dr. Becker has H&N Cancer that has returned and he is contemplating course of action but seems to not know anything about AXAL or ADXS----so I tweeted him at @Becker_MichaelD advising him to look into Advaxis, Axal and trials he might could access----maybe he could seek and get "compassionate use authorization------why dont we all tweet him asap recommending he research Advaxis and HPV related cancers especially H&N and then pursue authorization----he'll know how!
If he knows about it and isn't interested, I SURE would like to hear his reasoning for that also!
@Becker_MichaelD
GLTAL's
Easy----I researched him on LinkedIn and others including Twitter----found a ton of stuff but no easy way to contact him so I tweeted him suggesting he evaluate ADVAXIS AXAL for H&N trial and see what he could discover...you could try the same at @Becker_MichaelD. I am following him now to track what he says/knows/does. This is real....serious business, besides what I hope to be a wise, life changing investment (for the better)!
GLTAL's
Thanks mypeke---very informative and I would agree with you on applicability. hopefully, request has been presented and documented.
Bourbon, and maybe this agreement failed to include such dissolution language and then when someone stepped up to the table, Bristol or Astra---that's when the BOD found out and Dan had to go!!!
I hope not cause that would mean we are worth less to all other suitors and more or less dependent on Amgen for any BO.
mypeke......do you or anyone else know if we have to apply/request AA and if so is there a special procedure and/or cost to do so-----what is the downside to this being the first thing Lombardo would do?
GLTAL's
Yes indeed.....2-3% per day is good. it only takes 14 of those to get SP over 10 and 30 of those kind of days gets SP over 15!!!!!!
GLTAL's
My understanding is that I either have to sell them outright, pay $5/each to convert them to shares or they in fact expire worthless------I have WAY too many of them and it's my first foray into warrants myself---so, I could be wrong....
For those of us who bet hard on the warrants----the question is when to convert or sell so as to avoid them expiring worthless October 2018?
Any strong opinions or analysis to help guide us in this relatively short term major decision coming up?
GLTAL's
Easy....let's assume your theories on this are more or less correct, then, what in heck did DOC do to get sh** canned within a qtr of filing for EU and probable link up in EU for AXAL which would most likely have taken the SP high enough to buy enough time with the BOD and LTSH......heck, maybe even with FBG?
GLTAL's
Doesn't anything "material" have to be reported within like 4 days?
excel, unfortunately, based on sp activity, supply and demand and the market perception.....the one thing we know for sure is that shorts don't seem to be a bit fearful of anything happening and they have been of this persuasion ever since the clinical hold late 2015!!!!
what is going to change that and when????
GLTAL's
See link to a very good Journal type article on the GOG 265 study and comparative analysis as well as pointing to where it goes from here......
http://www.clinicaloncology.com/Other-Solid-Tumors/Article/07-17/Novel-Agent-Produces-Highest-OS-to-Date-in-PRmCC/41784?lipi=urn%3Ali%3Apage%3Ad_flagship3_feed%3B4u3E1vq7RJ%2BvcssPUe%2B9tA%3D%3D
Posted by Noelle Heber on LinkedIn just now.
GLTAL's
huskercat........if you don't mind sharing, please send file to me at cr_cook@bellsouth.net would be much appreciated! I came aboard March 2015, so I missed most of the J&E dissertations!
Thanks and GLTAL's
On LinkedIn Advaxis shows 130 employees listed and these aren't low level folks, so they may be averaging $100K each for over $1M per month labor plus 50% Fringe---so that's $20M annually w/o any trials, conferences, bonuses, legal, PR, patent/IP etc., etc-----looks like Dan took ADXS to the Lm Island and burnt the boats!
Get busy Lombardo......
GLTAL's